Welcome! Login | Register
 

Three Arrested for Selling Cocaine, Heroin in Worcester—Three Arrested for Selling Cocaine, Heroin in Worcester

Worcester Police to Swear in 8 New Officers on Friday—Worcester Police to Swear in 8 New Officers…

5 Things to Know About the Patriots Heading into the 2017 NFL Draft—5 Things to Know About the Patriots Heading…

Bradley’s 24 Points Helps Celtics to 108-97 Game 5 Win Over Bulls—Bradley's 24 Points Helps Celtics to 108-97 Game…

Boston Public Radio’s Eagan to be Keynote Speaker at Communicators Club Meeting—Boston Public Radio’s Eagan to be Keynote Speaker…

Worcester Chamber to Announce Winners of StartUp Worcester 2017—Worcester Chamber to Announce Winners of StartUp Worcester…

Red Sox Manage Only 4 Hits in 3-1 Loss to Yankees—Red Sox Manage Only 4 Hits in 3-1…

“EASY LOVE” At the Bull Mansion—"EASY LOVE" At the Bull Mansion

Worcester Carpenters Claim Wage Theft, Payroll Fraud at Front Street Project—Worcester Carpenters Claim Wage Theft, Payroll Fraud at…

MA Receives Nearly $12 Million in Federal Funding to Fight Opioid Epidemic—MA Receives Nearly $12 Million in Federal Funding…

 
 

AG Announces $68.5 Million Settlement with AstraZeneca

Friday, March 11, 2011

 

Attorney General Peter Kilmartin announced today that a $68.5 million dollar settlement has been reached with AstraZeneca Pharmaceuticals.

This settlement, which is the largest ever multi-state consumer protection-based pharmaceutical settlement, is expected to bring $908,838 to the state.

The settlement stems from a complaint alleging that AstraZeneca used deceptive practices to market the antipsychotic drug Seroquel for off-label uses, according to the Attorney General. The company was accused of withholding information on the drug’s dangerous potential side effects, in addition to the negative results of scientific study done that tested the safety of the drug.

“This settlement shows the commitment of this office to protect consumers from deceptive marketing and advertising practices by big pharmaceutical companies,” Kilmartin said.

Company promises changes

AstraZeneca has promised to alter the way that it markets Seroquel, eliminating the misleading practices in question. Along with the $68.5 million payment, under the settlement AstraZeneca must comply with provisions addressing numerous concerns that an extensive 3-year investigation yielded. For example, AstraZeneca must have policies in place to ensure that sales personnel do not promote to health care providers who are unlikely to prescribe Seroquel for an FDA-approved use.

Other states participating in the investigation and settlement were: Florida, Illinois, Arizona, California, Colorado, Connecticut, Delaware, Hawaii, Idaho, Iowa, Kansas, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Nebraska, Nevada, New Hampshire, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Texas, Vermont, Washington, West Virginia and Wisconsin.
 

 

Enjoy this post? Share it with others.

 

X

Stay Connected — Free
Daily Email